Homepage - JADPRO

For updated information about JADPRO Live 2022, please visit JADPROLive.com

For information about the JADPRO Workshop, please visit JADPROworkshop.com

CURRENT ISSUE Current Issue Cover

VOL 13 NO 7 • Sep/Oct 2022

IN THIS ISSUE

Insights Into the Publishing Process

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Management of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer C...

Fedricker D. Barber (1), Erick Campbell (1), Yuko Yamamura (1), Clover J. Patterson (1), Audrey C. Hartnett (1), Holly Kinahan (1), Victoria A. Miller (1), Amanda L. Brink (1), Anna Poullard (1), Gabriele E. Urschel (1), Andre Brantley (1), Isabel G. Cepeda (1), Poonam Goswami (1), Sheena Charles (1), Shincy Philip (1), Sara Bresser (1), Sandra Musekiwa-Adjei (1), Nageli Perez (1), Hung Le (1), Penny Phillips (2), Vivek Subbiah (1), Funda Meric-Bernstam (1,3,4), and Ecaterina E. Dumbrava (1)

The Impact of an Embedded Oncology Pharmacist in an Outpatient Oncology Center in the Treatment of Hematologic Malignancies

Denisse Mae Trinidad, PharmD, and Puja R. Patel, PharmD, BCOP

Ultrasound Evaluation of Carotid Artery Intima-Media Thickness: Effective Early Marker of Carotid Artery Disease in Adult Head and Neck Cancer Patients After...

Whitney Randolph, APRN, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP

TODAY'S NEWS

Study Focuses on Molecular Details of Pr...

A common, spontaneous mutation in blood stem cells...

Researchers Identify Potential Biomarker...

It may soon be possible to identify group 4 medull...

Novel Gamma Secretase Inhibitor Halts Pr...

Patients with rare desmoid tumors may finally have...

Fertility Preservation Procedures at Bre...

In a Swedish nationwide prospective cohort study r...

T-DXd for Patients With HER2-Low Metasta...

Patients who received fam-trastuzumab deruxtecan-n...

More News From Today

EDITORIALS & COMMENTARY

Advanced Practitioners as Allies and Advocates

Advanced practitioners (APs) are a growing proportion of the health-care team...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

Join us at #JADPROLive for this important ses...

about 19 hours ago via web

Join us tomorrow afternoon, Tues Oct 4 at 4:0...

about 1 days ago via web

RT @montypal: Tx @drenriquegrande! I was nerv...

about 1 days ago via web

RT @DrewMoghanaki: For those who missed it, h...

about 1 days ago via web

RT @MyriamChalabi: About the smile: the stand...

about 1 days ago via web

More Tweets

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.